Small molecules & peptides
PSMA I&T acetate
Precursor for radiometal-labelled PSMA I&T (PSMA: prostate-specific membrane antigen)
(R)-DOTAGA-(I-y)fk(Sub-KuE)
Sequence: (R)-DOTAGA-D-Tyr(3-I)-D-Phe-D-Lys[Sub-Glu-CO-Lys] acetate
Quality
Research Chemical
Characteristics
Molar mass 1498.37 (PSMA I&T)
CAS RN [2192281-54-0] (PSMA I&T)
Purity ≥ 95 %
- White to off-white solid
Certificates
CoA: appearance, MS (identity), HPLC (purity), net peptide content (reported)
Literature
Baum R.P. et al. ¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy. J. Nucl. Med. 2016, 57, 1006–1013.
Eiber M. et al. Systemic Radioligand Therapy with ¹⁷⁷Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer. J. Nucl. Med., 2016, 57(supplement 2): p. 61–61.
Schottelius M. et al. [¹¹¹In] PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res. 2015, 5, 68.
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/c30a7430-64f2-4c9b-9b60-a406d0d43829 | Precursor | Product No.: 99382 |
Related products
Product was added